Loading...
Thumbnail Image
Publication

Host immunity increases Mycobacterium tuberculosis reliance on cytochrome bd oxidase [preprint]

Cai, Yi
Jaecklein, Eleni
Mackenzie, Jared
Papavinasasundaram, Kadamba
Michigan State University
Chen, Xinchun
Africa Health Research Institute
Sassetti, Christopher M
Embargo Expiration Date
Link to Full Text
Abstract

In order to sustain a persistent infection, Mycobacterium tuberculosis (Mtb) must adapt to a changing environment that is shaped by the developing immune response. This necessity to adapt is evident in the flexibility of many aspects of Mtb metabolism, including a respiratory chain that consists of two distinct terminal cytochrome oxidase complexes. Under the conditions tested thus far, the bc1/aa3 complex appears to play a dominant role, while the alternative bd oxidase is largely redundant. However, presence of two terminal oxidases in this obligate pathogen implies that respiratory requirements might change during infection. We report that the cytochrome bd oxidase is specifically required for resisting the adaptive immune response. While the bd oxidase was dispensable for growth in resting macrophages and the establishment of infection in mice, this complex was necessary for optimal fitness after the initiation of adaptive immunity. This requirement was dependent on lymphocyte-derived interferon gamma (IFNγ), but did not involve nitrogen and oxygen radicals that are known to inhibit respiration in other contexts. Instead, we found that ΔcydA mutants were hypersusceptible to the low pH encountered in IFNγ-activated macrophages. Unlike wild type Mtb, cytochrome bd-deficient bacteria were unable to sustain a maximal oxygen consumption rate (OCR) at low pH, indicating that the remaining cytochrome bc1/aa3 complex is preferentially inhibited under acidic conditions. Consistent with this model, the potency of the cytochrome bc1/aa3 inhibitor, Q203, is dramatically enhanced at low pH. This work identifies a critical interaction between host immunity and pathogen respiration that influences both the progression of the infection and the efficacy of potential new TB drugs.

Source

bioRxiv 2020.08.21.260737; doi: https://doi.org/10.1101/2020.08.21.260737. Link to preprint on bioRxiv service.

Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1101/2020.08.21.260737
PubMed ID
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources

Now published in PLOS Pathogens doi: 10.1371/journal.ppat.1008911

Related Resources
Repository Citation
Rights
The copyright holder for this preprint (which was not peer-reviewed) is the author/funder. It is made available under a CC-BY 4.0 International license.